Cytokinetics Incorporated (CYTK) Declined -5.68% or -0.5 To Price $8.3 On Thursday


Cytokinetics Incorporated (CYTK) declined -5.68% or -0.5 to $8.3. It is close to 376358 shares traded, which is 98.75% compare to the average total volume 381137. The market cap of CYTK is $448.27 million. The year to date change is 0.57%. The 52 week price range is from $7.0 to $17.2. Price of CYTK have changed 3.53% during last week. It have changed 2.33% over last month, 11.39% over last 3 months, -39.10% over last 6 months and -32.31% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CYTK is 8.65. It is 4.22% above current price. The 200-day Moving Averages for CYTK is 11.77. It is 41.81% above current price. The 52-week High is 17.2. It is 107.23% from the current price. The 52-week Low is 7.0. It is -15.66% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CYTK is 8.82 on 2018-02-28. Short % to float is 6.35%. There are some statistics of CYTK. It is has market cap $448.27 million. The share outstanding is 54.01 million. The average volume is 381137. The revenue is 13.37M. It has 1.10B cash and 90.48M in debt. The percent of top 15 Institution holding is 71.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CYTK is -125.16%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CYTK is -54.97%.


Tags:

Share this post